
LM Funding America, Inc. Forms Death Cross, Signaling Bearish Trend Ahead
2025-10-06 15:22:41LM Funding America, Inc. has recently encountered a Death Cross, indicating a potential bearish trend. While daily moving averages reflect a bearish outlook, weekly and monthly indicators show mixed signals. The stock has outperformed the S&P 500 in the short term, but long-term performance remains troubling with significant declines.
Read MoreIs LM Funding America, Inc. technically bullish or bearish?
2025-09-20 19:57:27As of 2 September 2025, the technical trend for LM Funding America, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD indicating bearish momentum and the Bollinger Bands showing a mildly bearish signal. Additionally, the KST is bearish on a monthly basis, and the Dow Theory reflects a mildly bearish outlook as well. The daily moving averages are mildly bullish, but this is overshadowed by the overall bearish indicators. In terms of performance, the stock has significantly underperformed against the S&P 500 across multiple time frames, with a 1-month return of -47.37% compared to the S&P 500's 2.33%, and a 5-year return of -92.57% versus the S&P 500's 96.61%....
Read MoreIs LM Funding America, Inc. overvalued or undervalued?
2025-09-20 18:30:59As of 31 March 2023, the valuation grade for LM Funding America, Inc. moved from does not qualify to risky. The company is overvalued given its significant losses and negative return metrics. Key ratios include a Price to Book Value of 0.32, an EV to EBIT of -0.05, and an EV to EBITDA of -0.11, all indicating poor financial health and valuation concerns. In comparison to peers, LM Funding America, Inc. has a worse EV to EBITDA ratio of -5.2816 compared to BioNexus Gene Lab Corp. at -2.5208 and Greenwave Technology Solutions, Inc. at -1.1607, highlighting its relative underperformance. Additionally, the company's stock has underperformed significantly against the S&P 500, with a 1-year return of -47.15% compared to the index's 17.14%, reinforcing the notion of overvaluation....
Read More





